is retatrutide bad Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide Promises Big Weight Loss,

Yes, as with other incretin-based therapies, nausea, diarrhea, and reduced appetite are among the most commonly reported side effects, especially during dose escalation

Laboratory personnel

Theres no completed cardiovascular outcomes trial for retatrutide yet, the cause of dysesthesia isnt fully understood, and real-world data isnt available because the drug isnt approved

Those with severe laxity may see improvement but should have realistic expectations about the degree of change possible without surgery

The agency notes that its not always possible to estimate the frequency of these reactions since they are voluntarily reported

References Ali S, Ussher JR, Baggio LL, Kabir MG, Charron MJ, Ilkayeva O, Newgard CB, Drucker DJ (2014) Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction